Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / House Bills / H.R. 6963

H.R. 6963

To amend the Federal Food, Drug, and Cosmetic Act to strengthen requirements for postapproval studies for drugs approved using accelerated approval, and for other purposes.

Print stageDateSize⠃
Introduced in House2022-03-076.2K⠃⠗⠋